Suven Pharmaceuticals Ltd.

531.00 +3.80 ▲0.7%

26 September 2023, 04:01:00 PM
Volume: 15,476

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.suvenpharm.com
Market Cap 13,523.76 Cr.
Enterprise Value(EV) 13,524.91 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 16.67 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 31.86 Trailing Twelve Months Ending 2023-06
Industry PE 37.33 Trailing Twelve Months Ending 2023-06
Book Value / Share 72.90 Trailing Twelve Months Ending 2023-06
Price to Book Value 7.28 Calculated using Price: 531.00
Dividend Yield 0.94 Period Ending 2022-03
No. of Shares Subscribed 25.46 Cr. 254,564,956 Shares
FaceValue 1
About Suven Pharmaceuticals Ltd.
The company is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Suven Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

Suven Pharmaceuticals Ltd. Performance

1 Day
+0.72%
1 Week
-4.19%
1 Month
+2.63%
3 Month
+9.07%
6 Month
+12.50%
1 Year
+21.68%
2 Year
-1.78%
5 Year
10 Year

Suven Pharmaceuticals Ltd. Fundamental Ratios

4 years 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.92 37.80 30.47 30.48
Return on Capital Employed (%) 23.87 44.55 36.19 43.13
Return on Assets (%) 13.39 25.50 21.52 23.30

Suven Pharmaceuticals Ltd. Balance Sheet

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 590 845 1,181 1,527 1,735
Non Curr. Liab. 35 128 74 92 72
Curr. Liab. 191 320 322 348 159
Minority Int.
Equity & Liab. 816 1,292 1,576 1,967 1,966
Non Curr. Assets 393 781 910 702 955
Curr. Assets 423 511 667 1,265 1,011
Misc. Exp. not W/O
Total Assets 816 1,292 1,576 1,967 1,966

Suven Pharmaceuticals Ltd. Profit and Loss

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 378 834 1,010 1,320 1,349
Other Income 1 18 14 92 46
Total Income 378 852 1,024 1,413 1,395
Total Expenditure -206 -449 -567 -739 -766
PBIDT 172 403 457 674 629
Interest -3 -23 -12 -9 -5
Depreciation -12 -24 -32 -39 -49
Taxation -49 -88 -105 -214 -150
Exceptional Items
PAT 109 269 309 413 424
Minority Interest
Share Associate 48 54 41
Other Related Items
Consolidated Net Profit 109 317 362 454 424
Adjusted EPS 12 14 18 17

Suven Pharmaceuticals Ltd. Cash Flow

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 50 407 383 330
Cash Fr. Inv. -65 -413 -311 -136
Cash Fr. Finan. 26 7 -76 -156
Net Change 11 1 -5 37
Cash & Cash Eqvt 11 12 7 45

Suven Pharmaceuticals Ltd. Shareholding Pattern

9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00
Public 40.00 40.00 40.00 40.00 40.00 40.00 40.00 40.00 40.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Suven Pharmaceuticals Ltd. Announcements

Tue, 26 Sep 2023
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015
We are pleased to inform you that the Company has received an intimation on September 25 2023 that the Department of Pharmaceuticals Ministry of Chemicals and Fertilizers has granted its approval for acquisition of upto 76.1% shareholding in the Company by M/s. Berhyanda Limited Cyprus (Acquirer) by way of transfer of 12 75 37 043 equity shares aggregating to 50.1% of shareholding in the company from promoters of the Company and acquisition of up to 6 61 86 889 equity shares aggregating to 26% of shareholing in the Company from public shareholders through mandatory open offer. The aggregate foreign investment including investment from other foreign investors may be up to 90.1% shareholding in the Company.
Mon, 04 Sep 2023
Intimation Of Extension Of Time For Holding Annual General Meeting (AGM)
We wish to inform you that the Company Suven Pharmaceuticals Limited filed an applicaiton before the Registrar of Companies Hyderabad for an extension of holding Annual General Meeting (AGM) for the Financial Year 2022-23 which is due to be held on or before 30/09/2023 pursuant to the provisions of section 96(1) of the Companies Act 2023.The Registrar of Companies Hyderabad has approved the application and extended the date of AGM for 3 (three) months i.e. upto December 31 2023.
Mon, 14 Aug 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find enclosed the transcript of the earnings conference call for the quarter ended Juen 30 2023.

Suven Pharmaceuticals Ltd. Technical Scans

Tue, 26 Sep 2023
Higher Trade Quantity Higher Trade Quantity
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
MFI Above 80 MFI Above 80
Mon, 25 Sep 2023
Close Crossing Last Week Low Close Crossing Last Week Low

Suven Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,865.20 1,124.75 +0.1%
Divi's Laboratories Ltd. 99,629.03 3,752.95 +0.6%
Cipla Ltd. 93,955.61 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. 91,199.58 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. 72,659.42 5,051.00 -0.9%
Mankind Pharma Ltd. 70,114.99 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. 61,876.29 1,831.00 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.99 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-06 67.44 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-06 30.20 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.31 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.63 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 54.64 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.18 1,831.00 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.65 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-06 7.59 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-06 3.86 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.72 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.58 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 5.72 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.42 1,831.00 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,831.00 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,831.00 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,831.00 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,831.00 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,831.00 -0.9%

Suven Pharmaceuticals Ltd. FAQ's

What is Suven Pharma share price?

Can I buy Suven Pharma shares now?

What is the Dividend Yield of Suven Pharma?

What is the Market Cap of Suven Pharma?

What are the key metrics to analyse Suven Pharma?

What is the 52 Week High and Low of Suven Pharma?

What is the trend of Suven Pharma share price?